Enhanced antiviral efficacy of enterocin DD14 and lacticaseicin 30 against herpes simplex virus 1 (HSV-1) and the coronaviruses SARS-CoV-2 and HCoV in association with alginate nanoparticles - Archive ouverte HAL Accéder directement au contenu
Poster De Conférence Année : 2023

Enhanced antiviral efficacy of enterocin DD14 and lacticaseicin 30 against herpes simplex virus 1 (HSV-1) and the coronaviruses SARS-CoV-2 and HCoV in association with alginate nanoparticles

Fichier non déposé

Dates et versions

hal-04549350 , version 1 (17-04-2024)

Identifiants

  • HAL Id : hal-04549350 , version 1

Citer

Radja Teiar, Didier Lecouturier, Rabah Boukherroub, Didier Hober, Djamel Drider. Enhanced antiviral efficacy of enterocin DD14 and lacticaseicin 30 against herpes simplex virus 1 (HSV-1) and the coronaviruses SARS-CoV-2 and HCoV in association with alginate nanoparticles. 10èmes Journées du Réseau MultiFonction des Peptides Antimicrobiens (MuFoPAM), Oct 2023, Lille, France. ⟨hal-04549350⟩
0 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More